Drug
Ranolazine clinical trials
Also written Ranexa.
- studies test it
- 83
- open now
- 3
- in phase 3
- 16
- first study started
- 2004
Keep track of what changes. Save the Ranolazine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
- Ranexa
- 59
Combined with it in one product
Studies by the year they started
83 studies that test it; most in 2012 (18)
| Year | Studies |
|---|---|
| 2004 | 2 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 5 |
| 2011 | 13 |
| 2012 | 18 |
| 2013 | 9 |
| 2014 | 12 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 1 |
| 2022 | 1 |
| 2025 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 9
- Phase 2
- 23
- Phase 3
- 16
- Phase 4
- 27
- No phase
- 11
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 24 · Other 59
Gilead Sciences (18) · University of Roma La Sapienza (3) · University of Rochester (2) · University of California, San Diego (2) · Food and Drug Administration (FDA) (2) · North Florida Foundation for Research and Education (2) · Cedars-Sinai Medical Center (2) · University of Pennsylvania (2)
Often tested with
Tested in the same studies.
Verapamil (2) · Dofetilide (2) · Metformin (2) · Dronedarone (1) · Lopinavir-ritonavir drug combination (1) · Chloroquine (1) · Diltiazem (1) · Quinidine (1)
Studies
Open first, then newest update. How each study uses Ranolazine is read from its arms, and is right about nine times in ten.
Testing it · 83
- Feasibility Trial for a Right Ventricular Failure Platform TrialRecruitingPhase 2University of AlbertaNCT06570473Written as Ranolazine
- A Study of Ranolazine in ALSRecruitingPhase 2Swathy Chandrashekhar, MBBSNCT06527222Written as Ranolazine
- Inhibition of Late Sodium Current (INa) to Prevent Coronary MICROvascular Dysfunction in Patients Presenting With ST-Elevation Myocardial Infarction and Multivessel Disease: INaMICRON StudyRecruitingPhase 2/3Federico II UniversityNCT07380919Written as Ranolazine
- Reduce Crohn's-Associated Diarrhea With Sodium Channel TherapyTerminatedPhase 2Vanderbilt University Medical CenterNCT04456517Written as Ranolazine
- Safety and Efficacy of Ranolazine for the Treatment of Amyotrophic Lateral SclerosisCompletedPhase 2University of Kansas Medical CenterNCT03472950Written as Ranolazine 500 MG
- Ranolazine in Ischemic CardiomyopathyCompletedPhase 4Midwest Cardiovascular Research FoundationNCT01345188Written as Ranexa
- Impact of Ranolazine on Coronary Microcirculatory ResistanceCompletedNot applicableUniversity of New MexicoNCT01815957Written as Rnalozine
- Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary ArteriesWithdrawnPhase 4East Carolina UniversityNCT02423265Written as Ranolazine
- Long-term Efficacy Study of Sodium Channel Blocker in LQT3 PatientsCompletedPhase 2University of RochesterNCT01648205Written as Ranolazine
- Evaluation of Exercise Treadmill Test (ETT) Indices in Participants With Cardiovascular DiseaseTerminatedPhase 2Novartis PharmaceuticalsNCT01562041Written as Ranolazine 500 mg
- A Pilot Trial of Ranolazine to Treat Patients With Dilated CardiomyopathyCompletedPhase 2University Medical Centre LjubljanaNCT02133911Written as Ranolazine
- Ranolazine a Potential New Therapeutic ApplicationWithdrawnPhase 4Fondazione Policlinico Universitario Agostino Gemelli IRCCSNCT02687269Written as Ranolazine
- Effects of Ranolazine on Coronary Microvascular Dysfunction in Patients With Hypertrophic CardiomyopathyCompletedPhase 2IRCCS San RaffaeleNCT03953989Written as Ranolazine PR (prolonged-release) 500 mg 1 tablet bis in die and 750 mg 1 tablet bis in die
- Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial FibrillationCompletedPhase 2Gilead SciencesNCT01522651Written as Ranolazine
- Impact of Ranolazine in Blood Markers in Women With Angina and Metabolic SyndromeCompletedPhase 4University of FloridaNCT02252406Written as Ranolazine
- The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)TerminatedNot applicableCardiovascular Institute of the South Clinical Research CorporationNCT01705509Written as Ranolazine
- Ranolazine Mediated PVC Reduction in Ischemic Heart DiseaseCompletedPhase 2Kent Hospital, Rhode IslandNCT02360397Written as ranolazine
- The Effects of Ranolazine on Exercise Capacity in Patients With Heart Failure With Preserved Ejection FractionCompletedNot applicableUniversity of California, San DiegoNCT01505179Written as Ranolazine
- CiPA Phase 1 ECG Biomarker Validation StudyCompletedPhase 1Food and Drug Administration (FDA)NCT03070470Written as Ranolazine
- Ranolazine Among Unrevascularized Chronic Stable Angina PatientsCompletedPhase 2North Florida Foundation for Research and EducationNCT02265796Written as Ranolazine
Codes
What other systems call Ranolazine · ClinicalTrials.gg INT006587
- MeSH (NLM) D000069458RanolazineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) A6IEZ5M406RANOLAZINEConfirmed FDA, NLM, Wikidata
- RxNorm 35829Confirmed FDA, Wikidata
- Wikidata Q907104ranolazineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C66507RanolazineOne source FDA
- DrugBank DB00243One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000069458 | Ranolazine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | A6IEZ5M406 | RANOLAZINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 35829 | — | Confirmed FDA, Wikidata |
| Wikidata | Q907104 | ranolazine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C66507 | Ranolazine | One source FDA |
| DrugBank | DB00243 | — | One source Wikidata |
Also registered as ranolazine hydrochloride (UNII F71253DJUN).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.